Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have recently been diagnosed with prostate cancer confirmed by a tissue sample, with a Gleason score of 7 or higher (indicating clinically significant cancer)
- People who are planned to receive treatment aimed at curing the cancer, such as surgical removal of the prostate, radiation therapy, or treatments targeting hormones or using chemotherapy
- People who are able to have a specialised scan called a PSMA PET/CT before starting any prostate cancer treatment
- People who are 18 years of age or older
- People who are willing and able to attend follow-up appointments, including a second PSMA PET/CT scan at a later stage
- People who are willing to sign a form giving their informed consent to participate
Who may not be able to join:
- People who have already received any treatment for prostate cancer — including hormone therapy, radiation, chemotherapy, or surgery — before the first PSMA PET/CT scan
- People who are unable to have a PSMA PET/CT scan, for example due to a severe allergic reaction to the scan's tracer substance, or being unable to lie still and flat for the length of the scan
- People who have had another type of cancer (other than certain common skin cancers) within the past two years
- People with serious health conditions that, in the trial doctor's view, could interfere with participation or put the person at significant risk
- People who are unwilling or unable to provide signed informed consent
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 18700919857
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Absolute and relative change in SUVmax from baseline to follow-up PSMA PET
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.